| Title |
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
|
|---|---|
| Published in |
New England Journal of Medicine, November 2017
|
| DOI | 10.1056/nejmoa1701830 |
| Pubmed ID | |
| Authors |
Hongchao Pan, Richard Gray, Jeremy Braybrooke, Christina Davies, Carolyn Taylor, Paul McGale, Richard Peto, Kathleen I Pritchard, Jonas Bergh, Mitch Dowsett, Daniel F Hayes |
X Demographics
The data shown below were collected from the profiles of 326 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 107 | 33% |
| Spain | 18 | 6% |
| United Kingdom | 18 | 6% |
| Canada | 11 | 3% |
| Italy | 6 | 2% |
| Brazil | 5 | 2% |
| France | 5 | 2% |
| Mexico | 5 | 2% |
| Colombia | 3 | <1% |
| Other | 38 | 12% |
| Unknown | 110 | 34% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 200 | 61% |
| Practitioners (doctors, other healthcare professionals) | 64 | 20% |
| Scientists | 52 | 16% |
| Science communicators (journalists, bloggers, editors) | 10 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,046 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1046 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 136 | 13% |
| Student > Ph. D. Student | 126 | 12% |
| Student > Master | 94 | 9% |
| Other | 89 | 9% |
| Student > Bachelor | 82 | 8% |
| Other | 177 | 17% |
| Unknown | 342 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 319 | 30% |
| Biochemistry, Genetics and Molecular Biology | 128 | 12% |
| Agricultural and Biological Sciences | 45 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 34 | 3% |
| Nursing and Health Professions | 22 | 2% |
| Other | 104 | 10% |
| Unknown | 394 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1435. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2024.
All research outputs
#8,745
of 25,882,826 outputs
Outputs from New England Journal of Medicine
#440
of 32,727 outputs
Outputs of similar age
#125
of 345,711 outputs
Outputs of similar age from New England Journal of Medicine
#11
of 273 outputs
Altmetric has tracked 25,882,826 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,727 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 123.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,711 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.